Biotech innovation provides better-than-average salaries and pumps hundreds of billions of dollars into the U.S. economy annually—and the societal benefits of this innovation can […]
Studies show value of biotech IP for the economy and society Read More »
There are a lot of reasons to be skeptical of the HHS effort to bring international reference prices into Medicare via the proposed GLOBE
There was bipartisan support for the PASTEUR Act’s approach to addressing AMR and for NSCEB recommendations, both BIO priorities. A bipartisan Senate hearing sought
Senators seek solutions for AMR, maintaining US biotech leadership Read More »
On Tuesday July 28, the Arkansas State Board of Pharmacy suspended enforcement of a 2025 Arkansas law, Act 630, two months after a federal
Following court decision, Arkansas will not enforce Act 630 on drug distribution Read More »
The tap is opening up for venture capital in the biotech industry. Venture investment in biotech jumped 23% year-over-year in 2025 to $23 billion,
BIO 2026: How biotechs break the $100M barrier in funding rounds Read More »
Listening to people’s concerns about vaccines is key to helping them regain trust, according to experts promoting the need for life-saving immunizations. “We’ve all
BIO 2026: To restore trust in vaccines, listen to everyone’s concerns Read More »
“CAR-T cell therapies are remarkable drugs and are the gold standard for patients,” said Rachel Haurwitz, PhD, President & CEO of Caribou Biosciences. These
BIO 2026: Realizing the promise of CAR-T cell therapies Read More »
The FDA’s Pharmacy Compounding Advisory Committee (PCAC) will consider this week whether seven unapproved peptides should be added to the Section 503A Bulk Drug
FDA Advisory Committee to weigh whether to expand compounding of unapproved peptides Read More »
While the U.S. Food and Drug Administration (FDA) has faced significant change in recent years, industry leaders and agency officials alike say there are
BIO 2026: FDA leaders discuss restoring workforce, institutional knowledge Read More »
A new proposal to regulate federal grants risks destabilizing the system of government support essential to developing innovative therapies American patients need, the Biotechnology
BIO expresses concerns over proposed OMB rule to regulate federal grants Read More »
